Literature DB >> 2421767

Structural basis for the species selectivity of a fibrin-specific monoclonal antibody.

G R Matsueda, M N Margolies.   

Abstract

The structural determinant underlying the species specificity of a monoclonal anti-fibrin antibody (59D8) is the leucyl residue at position 5 in beta-chains of human fibrin. Anti-fibrin antibody 59D8 which had been elicited by immunization with human beta(1-7) peptide, Gly-His-Arg-Pro-Leu-Asp-Lys, binds to human and canine fibrins but not to bovine, ovine, or porcine fibrins. A comparison of the available amino acid sequence data suggested that the ability of anti-fibrin antibody 59D8 to discriminate among various fibrin beta-chains might be due to the amino acid at position 5. This was confirmed by competitive inhibition studies using synthetic fibrin-like peptides and determination of the amino acid sequences of the N-termini of ovine and porcine fibrin beta-chains. Edman degradation employing o-phthalaldehyde blocking permitted use of fibrin monomer rather than its separated constituent polypeptide chains. The same sequencing strategy was used to obtain partial sequence data for the alpha-chains of bovine, ovine, and porcine fibrin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421767     DOI: 10.1021/bi00354a039

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

Review 1.  Antibody imaging in the evaluation of cardiovascular diseases.

Authors:  B A Khaw; J Narula
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

2.  Correlation of beta-camera imaging and immunohistochemistry in radioimmunotherapy using 90Y-labeled monoclonal antibodies in ovarian cancer animal models.

Authors:  K J Kairemo; K Ljunggren; T Wahlström; T Stigbrand; S E Strand
Journal:  Cell Biophys       Date:  1994

3.  Complement Deficiencies Result in Surrogate Pathways of Complement Activation in Novel Polygenic Lupus-like Models of Kidney Injury.

Authors:  Sladjana Skopelja-Gardner; Lucrezia Colonna; Payton Hermanson; Xizhang Sun; Lena Tanaka; Joyce Tai; Yenly Nguyen; Jessica M Snyder; Charles E Alpers; Kelly L Hudkins; David J Salant; YuFeng Peng; Keith B Elkon
Journal:  J Immunol       Date:  2020-04-01       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.